NeuroPace, Inc. (NPCE)

Last Closing Price: 16.97 (2025-12-04)

Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

NeuroPace, Inc. (NPCE) had Consolidated Net Income/Loss of $-3.50M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$27.35M
$-3.50M
$6.19M
$21.17M
$29.95M
$-2.60M
$-0.90M
$-3.50M
$-3.50M
$-3.50M
$-3.50M
Consolidated Net Income/Loss
$-3.50M
$-3.50M
$-2.60M
$-3.31M
33.13M
33.13M
$-0.11
$-0.11
Balance Sheet Financials
$95.33M
$1.11M
$11.93M
$107.25M
$19.61M
$58.75M
$69.13M
$88.74M
$18.52M
$18.52M
$18.52M
33.28M
Cash Flow Statement Financials
$-11.51M
$-0.23M
$18.96M
$13.55M
$20.77M
$7.22M
$8.48M
--
--
Fundamental Metrics & Ratios
4.86
--
--
0.76
3.17
77.39%
-9.51%
-9.51%
--
-12.78%
-12.78%
$-11.75M
--
--
--
0.26
0.34
1.83
49.15
-18.88%
-18.88%
-3.26%
-4.52%
$0.56
$-0.35
$-0.35